Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Comprehensive Dermatologic Drug Therapy

Comprehensive Dermatologic Drug Therapy

9780323612111
720.67 zł
612.57 zł Save 108.10 zł Tax included
Lowest price within 30 days before promotion: 612.57 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders youre likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on todays full spectrum of topical, intralesional, and systemic drugs. Youll prescribe with confidence thanks to expert coverage of which drugs to use, when to use them, and adverse effects to monitor.

Product Details
Elsevier
81394
9780323612111
9780323612111

Data sheet

Publication date
2020
Issue number
4
Cover
hard cover
Pages count
858
Dimensions (mm)
216 x 276
Weight (g)
2540

  • Part I: Introduction

    1 Basic Principles of Pharmacology

    2 Principles for Maximizing the Safety of Dermatologic Drug Therapy

    3 Polymorphisms: Why Individual Drug Responses Vary

    4 Adherence to Drug Therapy

    5 Medical Decision Making

    Part II: Important Drug Regulatory Issues

    6 The FDA Drug Approval Process

    7 Pharmacovigilance: Verifying that Drugs Remain Safe

    8 Drugs Taken Off the Market: Important Lessons Learned

    Part III: Systemic Drugs for Infectious Diseases

    9 Systemic Antibacterial Agents

    10 Systemic Antifungal Agents

    11 Systemic Antiviral Agents

    12 Systemic Antiparasitic Agents

    Part IV: Systemic Immunomodulatory Drugs

    13 Systemic Corticosteroids

    14 Methotrexate

    15 Azathioprine

    16 Mycophenolates

    17 Cyclosporine

    18 Phosphodiesterase-4 and Janus Kinase Inhibitors

    19 Cytotoxic Agents

    20 Dapsone

    21 Antimalarial Agents

    22 Systemic Retinoids

    Part V: Drugs Used in Conjunction with UV or Visible Light

    23 Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities

    24 Extracorporeal Photochemotherapy (Photopheresis)

    25 Photodynamic Therapy

    Part VI: Biologic Therapeutics

    26 Tumor Necrosis Factor Inhibitors

    27 Interleukin 12/23 Inhibitors

    28 Interleukin 17 Inhibitors

    29 Interleukin 23 Inhibitors

    30 Rituximab

    31 Additional Biologic Therapeutics: Dupilumab, Omalizumab, Others

    Part VII: Miscellaneous Systemic Drugs

    32 Antihistamines

    33 Vasoactive and Antiplatelet Agents

    34 Antiandrogens and Androgen Inhibitors

    35 Psychotropic Agents

    36 Intravenous Immunoglobulin Therapy

    37 Systemic Anticancer Agents: Dermatologic Indications and Adverse Events

    38 Hedgehog Pathway Inhibitors

    39 Drugs for the Skinternist

    40 Miscellaneous Systemic Drugs

    Part VIII: Topical Drugs for Infectious Diseases

    41 Topical Antibacterial Agents

    42 Topical Antifungal Agents

    43 Topical and Intralesional Antiviral Agents

    44 Topical Antiparasitic Agents

    Part IX: Topical Immunomodulatory Drugs

    45 Topical Corticosteroids

    46 Topical Retinoids

    47 Topical and Intralesional Chemotherapeutic Agents

    48 Topical Calcineurin Inhibitors

    49 Topical Vitamin D3

    Part X: Miscellaneous Topical Drugs

    50 Sunscreens

    51 Therapeutic Shampoos

    52 a-Hydroxy Acids

    53 Chemical Peels

    54 Products for the Care of Chronic Wounds

    55 Agents Used for Treatment of Hyperkeratosis

    56 Irritants and Allergens: When to Suspect Topical Therapeutic Agents

    57 Miscellaneous Topical Agents

    Part XI: Injectable and Mucosal Routes of Drug Administration

    58 Local Anesthetics

    59 Injectable Dermal and Subcutaneous Fillers

    60 Botulinum Toxin Injections

    61 Oral Mucosal Therapeutics

    Part XII: Major Adverse Effects From Systemic Drugs

    62 Hepatotoxicity of Dermatologic Drug Therapy

    63 Hematologic Toxicity of Drug Therapy

    64 Drug-induced Malignancy

    65 Dermatologic Drugs During Pregnancy and Lactation

    66 Drug Interactions

    67 Cutaneous Drug Reactions With Systemic Features

    Part XIII: Special Pharmacology and Therapeutics Topics

    68 Informed Consent and Risk Management

    69 Compounding in Dermatology

    70 Dermatologic Drug Therapy in Children

    Appendix I Core Questions for Understanding Systemic Dermatologic Drugs

    Appendix II The Most Potentially Serious Drug Interactions

Comments (0)